Cargando…

Effectiveness of Bortezomib in Cardiac AL Amyloidosis: A Report of Two Cases

Cardiac involvement is a major prognostic determinant in patients with primary AL amyloidosis. The clinical results of standard therapeutic approaches are suboptimal. It has been recently shown that bortezomib, an inhibitor of the proteasome, can induce rapid favourable responses in AL amyloidosis i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nigrelli, Santi, Curciarello, Giuseppe, Ballo, Piercarlo, Michelassi, Stefano, Pizzarelli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970246/ https://www.ncbi.nlm.nih.gov/pubmed/24715916 http://dx.doi.org/10.1155/2014/627474

Ejemplares similares

Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report
por: Dattolo, Pietro, et al.
Publicado: (2010)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis
por: Brennan, Xavier, et al.
Publicado: (2022)

Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
por: Charaf, Edriss, et al.
Publicado: (2009)

Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
por: Hasan, Syed M., et al.
Publicado: (2018)

Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib
por: Jaipaul, Navin, et al.
Publicado: (2016)

Acute Inflammatory Bowel Disease Complicating Chronic Alcoholism and Mimicking Carcinoid Syndrome
por: Ballo, Piercarlo, et al.
Publicado: (2012)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
por: Ravichandran, Sriram, et al.
Publicado: (2021)

Ventricular Fibrillation after Bortezomib Therapy in a Patient with Systemic Amyloidosis
por: Yamasaki, Satoshi, et al.
Publicado: (2013)

First Case of Nodular Localized Primary Cutaneous Amyloidosis Treated With Bortezomib and Dexamethasone
por: Khan, Noman Ahmed Jang, et al.
Publicado: (2021)

Pomolidomide for relapsed/refractory light chain amyloidosis after resistance to both bortezomib and daratumumab: A case report
por: Li, Xian, et al.
Publicado: (2022)

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2017)

Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis
por: Fujimoto, Yuki, et al.
Publicado: (2021)

Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis
por: Hur, Joon Young, et al.
Publicado: (2021)

‘Here comes the story of the Hurricane’: a case report of AL cardiac amyloidosis and myocardial bridging
por: Cappannoli, Luigi, et al.
Publicado: (2022)

Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
por: Kastritis, E, et al.
Publicado: (2017)

AL type cardiac amyloidosis: a devastating fatal disease
por: Nasrullah, Adeel, et al.
Publicado: (2021)

Heparin-resistance in AL amyloidosis: a case report
por: van Ede, Elisabeth S., et al.
Publicado: (2023)

Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Management of pancreatitis related to Bortezomib treatment: report of two cases
por: Brulc, Erika, et al.
Publicado: (2018)

Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022)

Extensive cardiac FDG uptake in a patient with AL amyloidosis
por: Hatipoglu, Suzan, et al.
Publicado: (2023)

Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?
por: Cappuyns, Sarah, et al.
Publicado: (2022)

Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
por: Suzuki, Kenshi, et al.
Publicado: (2023)

Cardiac amyloidosis: A case report and review of literature
por: Taiwo, Adeyemi Adedamola, et al.
Publicado: (2019)

NEW-ONSET CARDIAC AMYLOIDOSIS WHILE IN REMISSION FROM SYSTEMIC AL AMYLOIDOSIS
por: Idowu, Abiodun, et al.
Publicado: (2023)

Catastrophic Cardiac Amyloidosis
por: Panduranga, Prashanth, et al.
Publicado: (2010)

Kidney-limited AL amyloidosis: a case report and review of the literature
por: Velayati, Sara, et al.
Publicado: (2021)

A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis
por: Innocenti, Samantha, et al.
Publicado: (2022)

Light-chain cardiac amyloidosis with neuropathy: a case report
por: Xu, Zhan-Wen, et al.
Publicado: (2015)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis
por: Abdallah, Al-Ola, et al.
Publicado: (2012)

PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE
por: Liu, Yang, et al.
Publicado: (2023)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Peripartum Cardiomyopathy Presenting with Predominant Left Ventricular Diastolic Dysfunction: Efficacy of Bromocriptine
por: Ballo, Piercarlo, et al.
Publicado: (2012)

AL Amyloidosis Presenting With Crescentic Glomerulonephritis
por: Wang, Ann A., et al.
Publicado: (2021)

Familial (ATTR) amyloidosis misdiagnosed as the primary (AL) variant: a case report
por: Dattilo, Philip B
Publicado: (2009)

Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease
por: Perfetto, Federico, et al.
Publicado: (2022)

Revisiting transthyretin related cardiac amyloidosis: Case report and review of literature
por: Sharma, Munish, et al.
Publicado: (2018)

Case report regarding the evolution of electrocardiographic and echocardiographic features in cardiac amyloidosis
por: Vervaat, Fabienne E, et al.
Publicado: (2021)

A Case Report of Cardiac Amyloidosis Highlighting the Importance of Strain Analysis
por: Sanchez, Andres Cordova, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8n06slh17vrg7mq5mtp4vlbat9